BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1373467)

  • 1. T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzees.
    Estaquier J; Boutillon C; Ameisen JC; Gras-Masse H; Lecocq JP; Barbier B; Dixson A; Tartar A; Capron A; Auriault C
    Mol Immunol; 1992 Apr; 29(4):489-99. PubMed ID: 1373467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of the T-cell response to a non-immunogenic peptide by its tandem association with a highly efficient T-helper peptide.
    Rouaix F; Gras-Masse H; Mazingue C; Ridel PR; Diesis E; Marguerite M; Estaquier J; Capron A; Tartar A; Auriault C
    Immunopharmacology; 1994; 28(2):137-43. PubMed ID: 7528185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of B-cell epitopes of nef HIV-I protein: immunogenicity related to their structure.
    Estaquier J; Boutillon C; Ameisen JC; Gras-Masse H; Delanoye A; Lecocq JP; Dixson A; Tartar A; Capron A; Auriault C
    Mol Immunol; 1992 Nov; 29(11):1337-45. PubMed ID: 1383694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitopes recognized by HIV-SF2 nef-specific CD4+ T-cell clones generated from HIV-1-uninfected donors.
    Wentworth PA; Bathurst I; Feucht PH; Erlich HA; Steimer KS
    Vaccine; 1994 Feb; 12(2):117-28. PubMed ID: 7511861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1).
    da Silva J; Hughes AL
    Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine mapping of HIV-1 Nef-epitopes by monoclonal antibodies.
    Siakkou H; Jahn S; Kienzle N; Ulrich R; Grötzinger C; Schneider T; Kohleisen B; Pauli G; Spohn R; Jung G
    Arch Virol; 1993; 128(1-2):81-95. PubMed ID: 7678193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nef and Gag synthetic peptide priming of antibody responses to HIV type 1 antigens in mice and primates.
    Vaslin B; Claverie JM; Benveniste O; Barre-Sinoussi FC; Dormont D
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1241-50. PubMed ID: 7531460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of the human immunodeficiency virus (HIV) recombinant nef gene product. Mapping of T-cell and B-cell epitopes in immunized chimpanzees.
    Bahraoui E; Yagello M; Billaud JN; Sabatier JM; Guy B; Muchmore E; Girard M; Gluckman JC
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1087-98. PubMed ID: 1702299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive delineation of antigenic and immunogenic properties of peptides derived from the nef HIV-1 regulatory protein.
    Estaquier J; Boutillon C; Gras-Masse H; Ameisen JC; Capron A; Tartar A; Auriault C
    Vaccine; 1993; 11(11):1083-92. PubMed ID: 8249426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine specificity of the B-cell epitopes recognized in HIV-1 NEF by human sera.
    Tähtinen M; Gombert F; Hyytinen ER; Jung G; Ranki A; Krohn KJ
    Virology; 1992 Mar; 187(1):156-64. PubMed ID: 1371024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper T-cell recognition of HIV-1 Tat synthetic peptides.
    Blazevic V; Ranki A; Mattinen S; Valle SL; Koskimies S; Jung G; Krohn KJ
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):881-90. PubMed ID: 7686223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
    Draenert R; Altfeld M; Brander C; Basgoz N; Corcoran C; Wurcel AG; Stone DR; Kalams SA; Trocha A; Addo MM; Goulder PJ; Walker BD
    J Immunol Methods; 2003 Apr; 275(1-2):19-29. PubMed ID: 12667667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein.
    Koenig S; Fuerst TR; Wood LV; Woods RM; Suzich JA; Jones GM; de la Cruz VF; Davey RT; Venkatesan S; Moss B
    J Immunol; 1990 Jul; 145(1):127-35. PubMed ID: 1694201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules.
    Culmann B; Gomard E; Kiény MP; Guy B; Dreyfus F; Saimot AG; Sereni D; Lévy JP
    Eur J Immunol; 1989 Dec; 19(12):2383-6. PubMed ID: 2481593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein.
    Couillin I; Culmann-Penciolelli B; Gomard E; Choppin J; Levy JP; Guillet JG; Saragosti S
    J Exp Med; 1994 Sep; 180(3):1129-34. PubMed ID: 7520468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation.
    Choppin J; Cohen W; Bianco A; Briand JP; Connan F; Dalod M; Guillet JG
    J Immunol; 2001 May; 166(10):6164-9. PubMed ID: 11342637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine.
    Gahéry-Ségard H; Pialoux G; Charmeteau B; Sermet S; Poncelet H; Raux M; Tartar A; Lévy JP; Gras-Masse H; Guillet JG
    J Virol; 2000 Feb; 74(4):1694-703. PubMed ID: 10644339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein.
    Culmann B; Gomard E; Kiény MP; Guy B; Dreyfus F; Saimot AG; Sereni D; Sicard D; Lévy JP
    J Immunol; 1991 Mar; 146(5):1560-5. PubMed ID: 1704397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human CD4+, HIV-SF2 Nef-specific T-cell clones for antigen-processing and presentation requirements and for cytotoxic activity.
    Wentworth PA; Steimer KS
    Vaccine; 1994 Aug; 12(10):885-94. PubMed ID: 7975829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.